SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

CORRESP Filing

bioAffinity Technologies, Inc.
Date: Sept. 16, 2025 · CIK: 0001712762 · Accession: 0001493152-25-013610

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-289944

Date
August 29, 2025
Author
Maria Zannes
Form
CORRESP
Company
bioAffinity Technologies, Inc.

Letter

bioAffinity Technologies, Inc.

Nacogdoches Road, Suite 216

San Antonio, Texas 78217

(210) 698-5334

September 16, 2025

VIA EDGAR

United States Securities and Exchange Commission

F Street, N.E.

Washington, D.C. 20549

Attention: Robert Augustin

Re: bioAffinity Technologies, Inc.

Registration Statement on Form S-1

Filed August 29, 2025

File No. 333-289944

Ladies and Gentlemen:

Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended (the "Act"), bioAffinity Technologies, Inc. (the "Company") respectfully requests that the effective date of the registration statement referred to above be accelerated so that it will become effective at 4:30 p.m., Eastern Time, on Tuesday, September 16, 2025, or as soon thereafter as possible.

Please notify Sean F. Reid of Sheppard Mullin Richter & Hampton LLP, counsel to the Company, at (212) 896-0610 as soon as possible as to the time the Registration Statement has been declared effective pursuant to this acceleration request.

Very truly yours,
BIOAFFINITY TECHNOLOGIES, INC.

Show Raw Text
CORRESP
 1
 filename1.htm

 bioAffinity
Technologies, Inc.

 3300
Nacogdoches Road, Suite 216

 San
Antonio, Texas 78217

 (210)
698-5334

 September
16, 2025

 VIA
EDGAR

 United
States Securities and Exchange Commission

 100
F Street, N.E.

 Washington,
D.C. 20549

 Attention:
Robert Augustin

 Re:
 bioAffinity
 Technologies, Inc.

 Registration
 Statement on Form S-1

 Filed
 August 29, 2025

 File
 No. 333-289944

 Ladies
and Gentlemen:

 Pursuant
to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended (the "Act"), bioAffinity Technologies,
Inc. (the "Company") respectfully requests that the effective date of the registration statement referred to above be accelerated
so that it will become effective at 4:30 p.m., Eastern Time, on Tuesday, September 16, 2025, or as soon thereafter as possible.

 Please
notify Sean F. Reid of Sheppard Mullin Richter & Hampton LLP, counsel to the Company, at (212) 896-0610 as soon as possible as to
the time the Registration Statement has been declared effective pursuant to this acceleration request.

 Very truly yours,

 BIOAFFINITY TECHNOLOGIES, INC.

 By:
 /s/
 Maria Zannes

 Name:
 Maria Zannes

 Title:
 Chief Executive Officer